Ocugen, Inc. (OCGN) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $596 million, Ocugen, Inc. is a small-cap company. The stock currently trades at $1.93, up 6.03% today, with a 52-week range of $0.52–$1.96.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | — | — | |
| 2023 | $-0.26 | $-0.26 | +31.6% | |
| 2022 | $-0.38 | $-0.38 | -26.7% | |
| 2021 | $-0.30 | $-0.30 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | $-0.79 | $-0.23 | +20.2% | |
| 2017 | $-0.99 | $-0.99 | +54.6% | |
| 2016 | $-2.18 | $-0.97 | — | |
| 2015 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-05 | 0001628280-25-010271 | SEC ↗ |
| 2023-12-31 | 2024-04-16 | 0001628280-24-016378 | SEC ↗ |
| 2022-12-31 | 2023-02-28 | 0001628280-23-005382 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0001628280-22-004085 | SEC ↗ |
| 2020-12-31 | 2021-03-19 | 0001628280-21-005124 | SEC ↗ |
| 2019-12-31 | 2020-03-27 | 0001628280-20-004221 | SEC ↗ |
| 2018-12-31 | 2019-03-22 | 0001564590-19-008830 | SEC ↗ |
| 2017-12-31 | 2018-03-15 | 0001564590-18-005711 | SEC ↗ |
| 2016-12-31 | 2017-03-16 | 0001193125-17-085372 | SEC ↗ |
| 2015-12-31 | 2016-03-10 | 0001193125-16-500103 | SEC ↗ |
| 2014-12-31 | 2015-03-27 | 0001193125-15-109659 | SEC ↗ |